Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report.

Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report. Psychol Med. 2010 Jan; 40(1):41-50.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.